SEATTLE, Feb. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering RavenQuest BioMed Inc.’s (CSE:RQB) (CNSX:RQB) (RQB.CN) acquisition of Bloomera, a licensed producer of medical cannabis in Ontario with a 2,000 kilograms per year capacity. RavenQuest BioMed has taken a Four Pillar approach to the market that involves working with indigenous populations, building out its own production, providing management services, and conducting research and development. And, a new letter of intent with an existing licensed producer could help accelerate all of these initiatives in the near-term.

Canada’s cannabis industry has become one of the largest and most mature markets in the world, as the only G20 country to have legalized both medical and recreational marijuana. While investors have many different opportunities in the space, they may want to focus on diversified companies that have near-term revenue and long-term intellectual property potential. This helps deliver value now and diversify against the risk of commoditization in the future.

Rapidly Expanding Market

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis later this year. Despite nearly 90 licensed producers, PI Financial anticipates a 187,885 kilogram shortfall in production by 2019. This creates a unique opportunity for licensed producers to ramp up production over the coming years to capitalize on the significant demand.

Licensed producers may be the most obvious way to capitalize on the market, but there are many other companies to consider in the space. Several companies are developing innovative growing and extraction technologies designed to help produce cannabis oils and enhance yields; biotech companies are developing innovative next-generation medicines; and, consulting firms are helping provide the support to grow the industry.

RavenQuest BioMed is a unique opportunity that takes advantage of many parts of the industry. In addition to its cultivation efforts, the company is engaged in research and development aimed at maximizing a metric that it feels is most relevant - grams per square foot. Its unique technologies have already demonstrated strong potential, while its consulting division is aimed at helping aspiring licensed producers get up and running.

RavenQuest’s New Acquisition

RavenQuest BioMed recently announced a binding letter of intent to acquire Bloomera, a licensed producer of medical cannabis in Ontario with a 2,000 kilograms per year capacity. Under the terms of the letter of intent, the company will acquire all of the outstanding shares of Bloomera in consideration for a cash payment of $15 million and the issuance of 10.4 million common shares of stock to existing Bloomera shareholders.

“The Bloomera acquisition accelerates our growth strategy by at least six months and opens the door to a much faster growth trajectory as we move forward,” said RavenQuest CEO George Robinson. “Markham, Ontario provides low cost access to the upcoming retail distribution network and the municipality has a large skilled workforce available … The addition of Bloomera provides us with direct access to the Greater Toronto Area - Canada’s largest cannabis market.”

In addition to Bloomera, the company owns Alberta Green Biotech, an Edmonton, Alberta-based facility with expected annual production of approximately 7,000 kilograms per year by mid-summer 2018 after it obtains approval from Health Canada. Management expects to increase annual production from the two facilities to 11,000 kilograms per year using its yield-maximization research developed in partnership with McGill.

Looking Ahead

RavenQuest BioMed Inc. (CSE:RQB) has a market capitalization of less than C$100 million despite its significant potential as a licensed producer, unique focus on indigenous populations, and its growing portfolio of growing technologies. With the potential acquisition of an existing licensed producer, the company will jumpstart its plans by immediately moving into production and implementing its yield-maximization technologies to prove their benefit.

Please follow the link to read the full article:
http://www.cannabisfn.com/ravenquest-acquires-licensed-producer-ontario/

For more information, visit the company’s website at www.rqbglobal.com.

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news. 

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

Contact

CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.